Brief: Femasys Initiates Enrollment In Pivotal Trial Of Its Permanent Birth Control Candidate Fembloc
03/08/2023 13:50
Femasys Inc FEMY.O :
* FEMASYS INITIATES ENROLLMENT IN PIVOTAL TRIAL OF ITS
PERMANENT
BIRTH CONTROL CANDIDATE FEMBLOC
Source text for Eikon: ID:nGNX5j71Ht
Further company coverage: FEMY.O
Recent news on Femasys
See all newsBrief: Femasys - Files For Resale Of Up To 28,124,997 Shares Of Common Stock - SEC Filing
Brief: Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc
Femasys Inc reports results for the quarter ended June 30 - Earnings Summary
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview